img

Global Afatinib Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Afatinib Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Afatinib report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Afatinib market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Afatinib industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Afatinib key companies include Boehringer Ingelheim, Hengrui Medicine and Beacon Pharma, etc. Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma are top 3 players and held % share in total in 2022.
Afatinib can be divided into 30mg Tables, 40mg Tables, 50mg Tables and 25mg Tables, etc. 30mg Tables is the mainstream product in the market, accounting for % share globally in 2022.
Afatinib is widely used in various fields, such as Hospital, Clinic, Drug Center and Other, etc. Hospital provides greatest supports to the Afatinib industry development. In 2022, global % share of Afatinib went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Afatinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Segment by Type
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other

Segment by Application


Hospital
Clinic
Drug Center
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Afatinib market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Afatinib introduction, etc. Afatinib Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Afatinib market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Afatinib
1.1 Afatinib Market Overview
1.1.1 Afatinib Product Scope
1.1.2 Afatinib Market Status and Outlook
1.2 Global Afatinib Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Afatinib Market Size by Region (2018-2034)
1.4 Global Afatinib Historic Market Size by Region (2018-2024)
1.5 Global Afatinib Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Afatinib Market Size (2018-2034)
1.6.1 North America Afatinib Market Size (2018-2034)
1.6.2 Europe Afatinib Market Size (2018-2034)
1.6.3 Asia-Pacific Afatinib Market Size (2018-2034)
1.6.4 Latin America Afatinib Market Size (2018-2034)
1.6.5 Middle East & Africa Afatinib Market Size (2018-2034)
2 Afatinib Market by Type
2.1 Introduction
2.1.1 30mg Tables
2.1.2 40mg Tables
2.1.3 50mg Tables
2.1.4 25mg Tables
2.1.5 20mg Tables
2.1.6 Other
2.2 Global Afatinib Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Afatinib Historic Market Size by Type (2018-2024)
2.2.2 Global Afatinib Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Afatinib Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Afatinib Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Afatinib Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Afatinib Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Afatinib Revenue Breakdown by Type (2018-2034)
3 Afatinib Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Drug Center
3.1.4 Other
3.2 Global Afatinib Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Afatinib Historic Market Size by Application (2018-2024)
3.2.2 Global Afatinib Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Afatinib Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Afatinib Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Afatinib Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Afatinib Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Afatinib Revenue Breakdown by Application (2018-2034)
4 Afatinib Competition Analysis by Players
4.1 Global Afatinib Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Afatinib as of 2022)
4.3 Date of Key Players Enter into Afatinib Market
4.4 Global Top Players Afatinib Headquarters and Area Served
4.5 Key Players Afatinib Product Solution and Service
4.6 Competitive Status
4.6.1 Afatinib Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Profile
5.1.2 Boehringer Ingelheim Main Business
5.1.3 Boehringer Ingelheim Afatinib Products, Services and Solutions
5.1.4 Boehringer Ingelheim Afatinib Revenue (US$ Million) & (2018-2024)
5.1.5 Boehringer Ingelheim Recent Developments
5.2 Hengrui Medicine
5.2.1 Hengrui Medicine Profile
5.2.2 Hengrui Medicine Main Business
5.2.3 Hengrui Medicine Afatinib Products, Services and Solutions
5.2.4 Hengrui Medicine Afatinib Revenue (US$ Million) & (2018-2024)
5.2.5 Hengrui Medicine Recent Developments
5.3 Beacon Pharma
5.3.1 Beacon Pharma Profile
5.3.2 Beacon Pharma Main Business
5.3.3 Beacon Pharma Afatinib Products, Services and Solutions
5.3.4 Beacon Pharma Afatinib Revenue (US$ Million) & (2018-2024)
5.3.5 Recent Developments
6 North America
6.1 North America Afatinib Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Afatinib Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Afatinib Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Afatinib Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Afatinib Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Afatinib Market Dynamics
11.1 Afatinib Industry Trends
11.2 Afatinib Market Drivers
11.3 Afatinib Market Challenges
11.4 Afatinib Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Afatinib Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Afatinib Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Afatinib Market Size Share by Region (2018-2024)
Table 4. Global Afatinib Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Afatinib Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Afatinib Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Afatinib Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Afatinib Revenue Market Share by Type (2018-2024)
Table 9. Global Afatinib Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Afatinib Revenue Market Share by Type (2024-2034)
Table 11. North America Afatinib Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Afatinib Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Afatinib Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Afatinib Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Afatinib Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Afatinib Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Afatinib Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Afatinib Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Afatinib Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Afatinib Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Afatinib Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Afatinib Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Afatinib Revenue Market Share by Application (2018-2024)
Table 24. Global Afatinib Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Afatinib Revenue Market Share by Application (2024-2034)
Table 26. North America Afatinib Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Afatinib Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Afatinib Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Afatinib Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Afatinib Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Afatinib Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Afatinib Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Afatinib Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Afatinib Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Afatinib Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Afatinib Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Afatinib Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Afatinib as of 2022)
Table 39. Date of Key Players Enter into Afatinib Market
Table 40. Global Afatinib Key Players Headquarters and Area Served
Table 41. Afatinib Product Solution and Service
Table 42. Global Afatinib Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Boehringer Ingelheim Basic Information List
Table 45. Boehringer Ingelheim Description and Business Overview
Table 46. Boehringer Ingelheim Afatinib Products, Services and Solutions
Table 47. Revenue (US$ Million) in Afatinib Business of Boehringer Ingelheim (2018-2024)
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Hengrui Medicine Basic Information List
Table 50. Hengrui Medicine Description and Business Overview
Table 51. Hengrui Medicine Afatinib Products, Services and Solutions
Table 52. Revenue (US$ Million) in Afatinib Business of Hengrui Medicine (2018-2024)
Table 53. Hengrui Medicine Recent Developments
Table 54. Beacon Pharma Basic Information List
Table 55. Beacon Pharma Description and Business Overview
Table 56. Beacon Pharma Afatinib Products, Services and Solutions
Table 57. Revenue (US$ Million) in Afatinib Business of Beacon Pharma (2018-2024)
Table 58. Beacon Pharma Recent Developments
Table 59. North America Afatinib Market Size by Country (2018-2024) & (US$ Million)
Table 60. North America Afatinib Market Size by Country (2024-2034) & (US$ Million)
Table 61. Europe Afatinib Market Size by Country (2018-2024) & (US$ Million)
Table 62. Europe Afatinib Market Size by Country (2024-2034) & (US$ Million)
Table 63. Asia-Pacific Afatinib Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 64. Asia-Pacific Afatinib Market Size by Region (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Afatinib Market Size by Region (2024-2034) & (US$ Million)
Table 66. Asia-Pacific Afatinib Market Share by Region (2018-2024)
Table 67. Asia-Pacific Afatinib Market Share by Region (2024-2034)
Table 68. Latin America Afatinib Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 69. Latin America Afatinib Market Size by Country (2018-2024) & (US$ Million)
Table 70. Latin America Afatinib Market Size by Country (2024-2034) & (US$ Million)
Table 71. Middle East & Africa Afatinib Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 72. Middle East & Africa Afatinib Market Size by Country (2018-2024) & (US$ Million)
Table 73. Middle East & Africa Afatinib Market Size by Country (2024-2034) & (US$ Million)
Table 74. Afatinib Market Trends
Table 75. Afatinib Market Drivers
Table 76. Afatinib Market Challenges
Table 77. Afatinib Market Restraints
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Afatinib Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Afatinib Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Afatinib Market Share by Regions: 2022 VS 2034
Figure 4. Global Afatinib Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Afatinib Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Afatinib Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Afatinib Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Afatinib Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Afatinib Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of 30mg Tables
Figure 11. Global 30mg Tables Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of 40mg Tables
Figure 13. Global 40mg Tables Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of 50mg Tables
Figure 15. Global 50mg Tables Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of 25mg Tables
Figure 17. Global 25mg Tables Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of 20mg Tables
Figure 19. Global 20mg Tables Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Product Picture of Other
Figure 21. Global Other Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Global Afatinib Market Size Share by Type: 2022 & 2034
Figure 23. North America Afatinib Revenue Market Share by Type (2018-2034)
Figure 24. Europe Afatinib Revenue Market Share by Type (2018-2034)
Figure 25. Asia-Pacific Afatinib Revenue Market Share by Type (2018-2034)
Figure 26. Latin America Afatinib Revenue Market Share by Type (2018-2034)
Figure 27. Middle East and Africa Afatinib Revenue Market Share by Type (2018-2034)
Figure 28. Hospital Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Clinic Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Drug Center Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Other Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 32. Global Afatinib Market Size Share by Application: 2022 & 2034
Figure 33. North America Afatinib Revenue Market Share by Application (2018-2034)
Figure 34. Europe Afatinib Revenue Market Share by Application (2018-2034)
Figure 35. Asia-Pacific Afatinib Revenue Market Share by Application (2018-2034)
Figure 36. Latin America Afatinib Revenue Market Share by Application (2018-2034)
Figure 37. Middle East and Africa Afatinib Revenue Market Share by Application (2018-2034)
Figure 38. Afatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 39. Global Top 5 and Top 10 Players Afatinib Market Share in 2022
Figure 40. North America Afatinib Market Share by Country (2018-2034)
Figure 41. U.S. Afatinib Market Size (2018-2034) & (US$ Million)
Figure 42. Canada Afatinib Market Size (2018-2034) & (US$ Million)
Figure 43. Germany Afatinib Market Size (2018-2034) & (US$ Million)
Figure 44. France Afatinib Market Size (2018-2034) & (US$ Million)
Figure 45. U.K. Afatinib Market Size (2018-2034) & (US$ Million)
Figure 46. Italy Afatinib Market Size (2018-2034) & (US$ Million)
Figure 47. Russia Afatinib Market Size (2018-2034) & (US$ Million)
Figure 48. Nordic Countries Afatinib Market Size (2018-2034) & (US$ Million)
Figure 49. Asia-Pacific Afatinib Market Share by Region (2018-2034)
Figure 50. China Afatinib Market Size (2018-2034) & (US$ Million)
Figure 51. Japan Afatinib Market Size (2018-2034) & (US$ Million)
Figure 52. South Korea Afatinib Market Size (2018-2034) & (US$ Million)
Figure 53. Southeast Asia Afatinib Market Size (2018-2034) & (US$ Million)
Figure 54. India Afatinib Market Size (2018-2034) & (US$ Million)
Figure 55. Australia Afatinib Market Size (2018-2034) & (US$ Million)
Figure 56. Latin America Afatinib Market Share by Country (2018-2034)
Figure 57. Mexico Afatinib Market Size (2018-2034) & (US$ Million)
Figure 58. Brazil Afatinib Market Size (2018-2034) & (US$ Million)
Figure 59. Middle East & Africa Afatinib Market Share by Country (2018-2034)
Figure 60. Turkey Afatinib Market Size (2018-2034) & (US$ Million)
Figure 61. Saudi Arabia Afatinib Market Size (2018-2034) & (US$ Million)
Figure 62. UAE Afatinib Market Size (2018-2034) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries